The chemical class known as Dynlt1c Inhibitors represents a specialized group of compounds designed to target and inhibit the activity of the Dynlt1c protein. Dynlt1c, identified through advanced molecular biology research, plays a significant role in various cellular functions. The activity of this protein is crucial in the context of cellular processes, and its function can vary depending on the cellular environment and external stimuli. Inhibitors targeting Dynlt1c are developed with a high degree of specificity, aiming to selectively bind to this protein and modulate its biological activity. The binding of these inhibitors to Dynlt1c is a critical mechanism, as it directly affects the biochemical pathways in which Dynlt1c is involved. By inhibiting the activity of Dynlt1c, these compounds are designed to influence the associated cellular mechanisms, which are vital for maintaining cellular balance and functionality.
The development of Dynlt1c Inhibitors is an intricate task that combines elements of molecular biology, chemistry, and structural biology. The process begins with a comprehensive understanding of the structure and functional dynamics of the Dynlt1c protein. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are employed to gain a detailed perspective of the target protein. This foundational knowledge is crucial for the rational design of inhibitors that are both effective in their interaction and highly selective for their target. These inhibitors are typically small molecules, optimized to penetrate cellular membranes efficiently and to establish a stable and potent interaction with Dynlt1c. The molecular design of these inhibitors is carefully refined to ensure a robust interaction with the target protein, typically involving hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is evaluated through various biochemical assays in vitro. These assays are vital for determining the inhibitors' ability to inhibit the activity of Dynlt1c, assessing factors such as potency, specificity, and overall interaction dynamics. These studies provide essential insights into the behavior of the inhibitors, laying the groundwork for further research into their mechanism of action and interaction dynamics within cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Intercalates DNA, preventing RNA synthesis by inhibiting RNA polymerase, thus potentially suppressing gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, leading to decreased mRNA synthesis and potentially reducing gene expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II transcription elongation, affecting mRNA production and gene expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA polymerase II activity, which can lead to downregulation of gene expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits cyclin-dependent kinases, potentially affecting transcription regulation and gene expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits translation initiation, which could potentially suppress protein synthesis including that of Dynlt1c. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits protein synthesis by preventing the initial elongation step of translation, affecting gene expression at the translational level. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptidyl transferase activity of the ribosome, impeding protein synthesis and possibly affecting gene expression. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, potentially affecting nucleotide biosynthesis and gene expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during translation, which can lead to the downregulation of protein synthesis. | ||||||